Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

11/10/2016 Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective 14/08/2013 International Society for Medical Publication Professionals Code of Ethics 14/08/2013 Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials 14/08/2013 What should be done to tackle ghostwriting in the medical literature? 11/07/2013 Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest 05/07/2013 Authors’ Submission Toolkit: a practical guide to getting your research published

Blog archives

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More